Role of the tumour protein P53 gene in human cervical squamous carcinoma cells: Discussing haematopoietic cell‑specific protein 1‑associated protein X‑1‑induced survival, migration and proliferation

Qian,Bing; Zhao,Li‑Jun; Teng,Fang; Gao,Ling‑Juan; Shen,Rong

doi:10.3892/ol.2018.8886

Role of the tumour protein P53 gene in human cervical squamous carcinoma cells: Discussing haematopoietic cell‑specific protein 1‑associated protein X‑1‑induced survival, migration and proliferation

Authors:
- Bing Qian
- Li‑Jun Zhao
- Fang Teng
- Ling‑Juan Gao
- Rong Shen
View Affiliations

Affiliations: Department of Gynaecological Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210009, P.R. China, Department of Gynaecology, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu 210004, P.R. China
Published online on: June 4, 2018 https://doi.org/10.3892/ol.2018.8886
Pages: 2629-2637

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The haematopoietic cell‑specific protein 1‑associated protein X‑1 (HAX‑1), as a mitochondrial membrane protein, induces cancer progression and metastasis. The present study aimed to investigate the role of HAX‑1‑inducedsurvival, migration and proliferation of human cervical squamous carcinoma cells and to elucidate its potential molecular mechanisms. The level of HAX‑1 was examined by quantitative polymerase chain reaction and western blot analyses. The survival, migration and proliferation of the human cervical squamous carcinoma SiHa cell line were measured by the water‑soluble tetrazolium salt (WST‑1) assay, Transwell assay and 3H‑thymidine incorporation into DNA (3H‑TdR) assay, respectively. The intracellular reactive oxygen species (ROS) was estimated by the fluorescence of H2DCFDA, and the mitochondrial membrane potential was tested using a JC‑1 probe. The expression of the HAX‑1 gene was significantly increased in human cervical carcinoma tissues relative to non‑cancerous cervix tissues. Overexpression of HAX‑1 increased the survival, migration and proliferation ability of SiHa cells, decreased the production of ROS, and maintained the integrity of the mitochondrial membrane and morphology. The effect brought on these cells could be abrogated by the addition of wild‑type tumour protein P53 (p53) or carbonyl cyanide‑p‑trifluoro methoxyphenylhydrazone‑induced mitochondrial dysfunction. In summary, these data support the notion that HAX‑1 induced the survival, migration and proliferation of human cervical squamous carcinoma cells by inhibiting its downstream regulatory factor p53 in SiHa cells.

View Figures

View References

1	Karageorgopoulou S, Kostakis ID, Gazouli M, Markaki S, Papadimitriou M, Bournakis E, Dimopoulos MA and Papadimitriou CA: Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy. BMC Cancer. 17:4512017. View Article : Google Scholar : PubMed/NCBI
2	Sodhani P, Gupta S, Gupta R and Mehrotra R: Bacterial vaginosis and cervical intraepithelial neoplasia: Is there an association or is co-existence incidental? Asian Pac J Cancer Prev. 18:1289–1292. 2017.PubMed/NCBI
3	Kwon MJ, Kang SY, Nam ES, Cho SJ and Rho YS: HIPK2 overexpression and its prognostic role in human papillomavirus-positive tonsillar squamous cell carcinoma. Biomed Res Int. 2017:10564272017. View Article : Google Scholar : PubMed/NCBI
4	Borcoman E and Tourneau CL: Pembrolizumab in cervical cancer: latest evidence and clinical usefulness. Ther Adv Med Oncol. 9:431–439. 2017. View Article : Google Scholar : PubMed/NCBI
5	Karan D, Tawfik O and Dubey S: Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer. Sci Rep. 7:43782017. View Article : Google Scholar : PubMed/NCBI
6	Rosania R, Varbanova M, Wex T, Langner C, Bornschein J, Giorgio F, Ierardi E and Malfertheiner P: Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer. BMC Gastroenterol. 17:842017. View Article : Google Scholar : PubMed/NCBI
7	Shen S, Li W, Ouyang MA and Wang J: Structure-activity relationship of triterpenes and derived glycosides against cancer cells and mechanism of apoptosis induction. Nat Prod Res. 32:654–661. 2018. View Article : Google Scholar : PubMed/NCBI
8	Paech F, Bouitbir J and Krähenbühl S: Hepatocellular toxicity associated with tyrosine kinase inhibitors: Mitochondrial damage and inhibition of glycolysis. Front Pharmacol. 8:3672017. View Article : Google Scholar : PubMed/NCBI
9	Chen J, Wang YX, Dong MQ, Zhang B, Luo Y, Niu W and Li ZC: Reoxygenation reverses hypoxic pulmonary arterial remodeling by inducing smooth muscle cell apoptosis via reactive oxygen species-mediated mitochondrial dysfunction. J Am Heart Assoc. 6(pii): e0056022017. View Article : Google Scholar : PubMed/NCBI
10	Frumovitz M, Burzawa JK, Byers LA, Lyons YA, Ramalingam P, Coleman RC and Brown J: Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol Oncol. 141:588–591. 2016. View Article : Google Scholar : PubMed/NCBI
11	Yuan JY, Liu LY, Wang P, Li ZF, Ni L, Wang A, Xiao SX, Song TS and Huang C: Small-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells. Oncol Lett. 1:649–655. 2010. View Article : Google Scholar : PubMed/NCBI
12	Lee SA, Kim JW, Roh JW, Choi JY, Lee KM, Yoo KY, Song YS and Kang D: Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women. Gynecol Oncol. 93:14–18. 2004. View Article : Google Scholar : PubMed/NCBI
13	You B, Cao X, Shao X, Ni H, Shi S, Shan Y, Gu Z and You Y: Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma. Oncotarget. 7:12505–12524. 2016. View Article : Google Scholar : PubMed/NCBI
14	Wang Y, Huo X, Cao Z, Xu H, Zhu J, Qian L, Fu H and Xu B: HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation. Int J Clin Exp Pathol. 8:8099–8106. 2015.PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Li Q, Shen F and Wang C: TUC338 promotes cell migration and invasion by targeting TIMP1 in cervical cancer. Oncol Lett. 13:4526–4532. 2017. View Article : Google Scholar : PubMed/NCBI
17	Chen AH, Qin YE, Tang WF, Tao J, Song HM and Zuo M: MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer. Cancer Cell Int. 17:632017. View Article : Google Scholar : PubMed/NCBI
18	Nishi K, Luo H, Ishikura S, Doi K, Iwaihara Y, Wills L, Baillie GS, Sakata T, Shirasawa S and Tsunoda T: Apremilast induces apoptosis of human colorectal cancer cells with mutant KRAS. Anticancer Res. 37:3833–3839. 2017.PubMed/NCBI
19	Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U and Watanabe T: HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J Immunol. 158:2736–2744. 1997.PubMed/NCBI
20	Chao JR, Parganas E, Boyd K, Hong CY, Opferman JT and Ihle JN: Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature. 452:98–102. 2008. View Article : Google Scholar : PubMed/NCBI
21	Fulda S and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
22	Halestrap AP, Clarke SJ and Javadov SA: Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc Res. 61:372–385. 2004. View Article : Google Scholar : PubMed/NCBI
23	Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
24	Wu JY, Li M, Cao LJ, Sun ML, Chen D, Ren HG, Xia Q, Tao ZT, Qin ZH, Hu QS and Wang GH: Protease Omi cleaving Hax-1 protein contributes to OGD/R-induced mitochondrial damage in neuroblastoma N2a cells and cerebral injury in MCAO mice. Acta Pharmacol Sin. 36:1043–1052. 2015. View Article : Google Scholar : PubMed/NCBI
25	Li M, Tang Y, Zang W, Xuan X, Wang N, Ma Y, Wang Y, Dong Z and Zhao G: Analysis of HAX-1 gene expression in esophageal squamous cell carcinoma. Diagn Pathol. 8:472013. View Article : Google Scholar : PubMed/NCBI
26	Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J, Siedlecki JA and Grzybowska EA: HAX-1overexpression, splicing and cellular localization in tumors. BMC Cancer. 10:762010. View Article : Google Scholar : PubMed/NCBI
27	Sun X, Li Y, Zheng M, Zuo W and Zheng W: MicroRNA-223 increases the sensitivity of triple-negative breast cancer stem cells to TRAIL-induced apoptosis by targeting HAX-1. PLoS One. 11:e01627542016. View Article : Google Scholar : PubMed/NCBI
28	Banerjee A, Saito K, Meyer K, Banerjee S, Ait-Goughoulte M, Ray RB and Ray R: Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition. J Virol. 83:9663–9671. 2009. View Article : Google Scholar : PubMed/NCBI
29	Sun SJ, Feng L, Zhao GQ and Dong ZM: HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells. Dig Dis Sci. 57:1838–1846. 2012. View Article : Google Scholar : PubMed/NCBI
30	Hirasaka K, Mills EM, Haruna M, Bando A, Ikeda C, Abe T, Kohno S, Nowinski SM, Lago CU, Akagi K, et al: UCP3 is associated with Hax-1 in mitochondria in the presence of calcium ion. Biochem Biophys Res Commun. 472:108–113. 2016. View Article : Google Scholar : PubMed/NCBI
31	Xia C, Shui L, Lou G, Ye B, Zhu W, Wang J, Wu S, Xu X, Mao L, Xu W, et al: 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop. Sci Rep. 7:43962017. View Article : Google Scholar : PubMed/NCBI
32	Hoffman S, Martin D, Meléndez A and Bargonetti J: C. elegans CEP-1/p53 and BEC-1 are involved in DNA repair. PLoS One. 9:e888282014.
33	Ai G, Dachineni R, Kumar DR, Marimuthu S, Alfonso LF and Bhat GJ: Aspirin acetylates wild type and mutant p53 in colon cancer cells: Identification of aspirin acetylated sites on recombinant p53. Tumour Biol. 37:6007–6016. 2016. View Article : Google Scholar : PubMed/NCBI
34	Delbridge AR, Pang SH, Vandenberg CJ, Grabow S, Aubrey BJ, Tai L, Herold MJ and Strasser A: RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice. J Exp Med. 213:2039–2048. 2016. View Article : Google Scholar : PubMed/NCBI
35	Iwanicki MP, Chen HY, Iavarone C, Zervantonakis IK, Muranen T, Novak M, Ince TA, Drapkin R and Brugge JS: Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. JCI Insight. 1:e868292016. View Article : Google Scholar : PubMed/NCBI
36	Wang M, Zhang Y, Wang T, Zhang J, Zhou Z, Sun Y, Wang S, Shi Y, Luan X, Zhang Y, et al: The USP7 inhibitor P5091 induces cell death in ovarian cancers with different P53 status. Cell Physiol Biochem. 43:1755–1766. 2017. View Article : Google Scholar : PubMed/NCBI